Cargando…

Exploring the acceptability of controlled human infection with SARSCoV2—a public consultation

Rapid development of an effective vaccine for SARSCoV2 is a global priority. A controlled human infection model (CHIM) would accelerate the efficacy assessment of candidate vaccines. This strategy would require deliberate exposure of volunteers to SARSCoV2 with no currently available treatment and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gbesemete, D., Barker, M., Lawrence, W. T., Watson, D., de Graaf, H., Read, R. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339437/ https://www.ncbi.nlm.nih.gov/pubmed/32635912 http://dx.doi.org/10.1186/s12916-020-01670-2

Ejemplares similares

On the case report of Platypnea-orthodeoxia after SARSCoV-2 pneumonia plus historical notes
por: Corrêa, Paulo César Rodrigues Pinto
Publicado: (2020)

Impact of liver enzymes on SARSCoV-2 infection and on the severity of clinical disease
por: Servín-Caamaño, A., et al.
Publicado: (2020)

Aspartate aminotransferase as predictor of severity in SARSCoV-2 infection: linear regression model
por: Servín-Caamaño, A., et al.
Publicado: (2020)

Is SARSCoV-2 nasopharyngeal swab still a gold standard in children?
por: Marino, Silvia, et al.
Publicado: (2020)

So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development
por: Grady, Christine, et al.
Publicado: (2020)

SARSCoV-2 serostatus amongst vaccinated employees at a pediatric hospital system
por: Devaraj, Sridevi, et al.
Publicado: (2021)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

Vaccination against SARSCoV-19 among psychiatric patients at the central Greek hospital
por: Anagnostaki, M. E., et al.
Publicado: (2023)

Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?
por: Pelechas, Eleftherios, et al.
Publicado: (2020)

Early Identification of IgA Anti-SARSCoV-2 in Milk of Mother With COVID-19 Infection
por: Lebrão, Cibele Wolf, et al.
Publicado: (2020)

Indian association of medical microbiologists (IAMM) position paper on guidelines for COVID and SARSCoV2 infections
por: Ravi, V., et al.
Publicado: (2023)

495. De novo emergence of resistance mutations during treatment of SARSCoV-2 infection in immunocompromised patients
por: Johnson, Katherine, et al.
Publicado: (2023)

Case report of a neonate with high viral SARSCoV-2 loads and long-term virus shedding
por: Slaats, Monique A.L.J., et al.
Publicado: (2020)

Central retinal artery occlusion after vaccination with whole virion inactivated SARSCoV- 2 vaccine Covaxin
por: Thakar, Meenakshi, et al.
Publicado: (2022)

Immune transcriptomes of highly exposed SARSCoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community
por: Lee, Hye Kyung, et al.
Publicado: (2020)

Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2
por: Anupama, Y.J., et al.
Publicado: (2021)

BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age
por: Bates, Timothy A., et al.
Publicado: (2022)

Evolución temporal de las variantes de SARSCoV-2 circulantes en el área sanitaria de Cádiz
por: Ibañez-López, Cristina, et al.
Publicado: (2023)

The impact of lockdown enforcement during the SARSCoV-2 pandemic on the timing of presentation and early outcomes of patients with ST-elevation myocardial infarction
por: Kobo, Ofer, et al.
Publicado: (2020)

Gastrointestinal tract diseases as a risk factor for SARSCoV2 rectal shedding? An Italian report on 10 COVID-19 patients
por: Patrì, Angela, et al.
Publicado: (2021)

Corrigendum: Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARSCoV-2 Nucleocapsid protein
por: Visvabharathy, Lavanya, et al.
Publicado: (2023)

Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia
por: Oltolini, Chiara, et al.
Publicado: (2023)

Truncated ring-A amaryllidaceae alkaloid modulates the host cell integrated stress response, exhibiting antiviral activity to HSV-1 and SARSCoV-2
por: McNulty, James, et al.
Publicado: (2023)

Cohort profile: The UK COVID-19 Public Experiences (COPE) prospective longitudinal mixed-methods study of health and well-being during the SARSCoV2 coronavirus pandemic
por: Phillips, Rhiannon, et al.
Publicado: (2021)

445 Inflammation in normal COVID-19 airway due to inhibition of cystic fibrosis transmembrane conductance regulator signaling by the SARSCoV-2 Spike protein
por: Caohuy, H., et al.
Publicado: (2022)

The Impact of COVID-19 on SARSCoV-2-Negative Elderly Patients with Hip Fractures: A Single-Center Retrospective Study from Shanghai, China
por: Zhao, Jinhui, et al.
Publicado: (2022)

1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy
por: Zambelli, A., et al.
Publicado: (2020)

Coupling of right ventricular function to pulmonary circulation as an independent predictor for non invasive ventilation failure in SARSCoV 2-related acute respiratory distress syndrome
por: Lazzeri, Chiara, et al.
Publicado: (2022)

High concordance in SARSCoV-2 detection between automated (Abbott m2000) and manual (DaAn gene) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon
por: Fainguem, Nadine Nguendjoung, et al.
Publicado: (2022)

Comportamiento de la infección SARSCoV-2 (COVID-19) en pacientes con diabetes mellitus tipo 2 en una unidad de cuidados respiratorios
por: Hernández-Solís, Alejandro, et al.
Publicado: (2023)

Pacientes con inmunización frente a SARSCoV-2 que han requerido ingreso hospitalario por neumonía COVID-19 en un hospital comarcal (Sierrallana-Cantabria)
por: Martínez, Paula Hernández, et al.
Publicado: (2022)

Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study” [Life Sci. 253 (2020) 117592]
por: Elfiky, Abdo A.
Publicado: (2020)

The Laboratory Consultant
Publicado: (1928)

The Need for Consultation
Publicado: (1923)

SARS_CoV2 RBD gene transcription cannot be driven by CMV promoter
por: Xie, Lilan, et al.
Publicado: (2021)

On finding acceptance
por: Chen, D.
Publicado: (2023)

Long Distance Consultations
Publicado: (1913)

Exploring the barriers for guideline-based management of dementia amongst consultants in Kerala, South India: A qualitative study
por: Sreelakshmi, P. Raghunath, et al.
Publicado: (2022)

Isolation Hospital Consultants' Fees
por: Nash, Edwin H. T.
Publicado: (1922)

Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines
por: Maestroni, Georges
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2u9s7vmrpkhd7o94n7ujj0fo5r